Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-03-29 Purchase |
2022-03-30 7:57 pm |
NexImmune Inc. | NEXI | Jones Kristi President and CEO |
10,000 | $3.74 | $37,400 | 73,078 (Direct) |
View |
2022-03-24 Purchase |
2022-03-28 4:15 pm |
NexImmune Inc. | NEXI | Verstandig Grant Director |
190,600 | $3.9364 | $750,274 | 905,495 (Direct) |
View |
2022-03-23 Purchase |
2022-03-24 4:15 pm |
NexImmune Inc. | NEXI | BARER SOL J Director |
10,000 | $2.6653 | $26,653 | 3,402,404 (Indirect Direct) |
View |
2022-03-22 Purchase |
2022-03-23 4:15 pm |
NexImmune Inc. | NEXI | BARER SOL J Director |
30,000 | $2.41 | $72,300 | 3,392,404 (Indirect Direct) |
View |
2022-03-21 Purchase |
2022-03-22 4:15 pm |
NexImmune Inc. | NEXI | BARER SOL J Director |
30,000 | $2.136 | $64,080 | 3,362,404 (Indirect Direct) |
View |
2022-03-18 Purchase |
2022-03-21 4:10 pm |
NexImmune Inc. | NEXI | BARER SOL J Director |
30,000 | $2.107 | $63,210 | 3,332,404 (Indirect Direct) |
View |
2021-02-17 Purchase |
2021-02-19 4:30 pm |
NexImmune Inc. | NEXI | Jones Kristi Chief Operating Officer |
911 | $17 | $15,487 | 63,078 (Direct) |
View |
2021-02-17 Purchase |
2021-02-19 4:30 pm |
NexImmune Inc. | NEXI | ZELDIS JEROME B Executive VP of Research & Dev |
5,882 | $17 | $99,994 | 5,882 (Direct) |
View |
2021-02-17 Purchase |
2021-02-19 4:25 pm |
NexImmune Inc. | NEXI | Verstandig Grant Director |
175,000 | $17 | $2,975,000 | 714,895 (Direct) |
View |
2021-02-17 Purchase |
2021-02-19 4:20 pm |
NexImmune Inc. | NEXI | BARER SOL J Director |
60,000 | $17 | $1,020,000 | 1,714,391 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-04-05 Option Award |
2022-04-07 7:12 pm |
N/A 2032-04-04 |
NexImmune Inc. | NEXI | ZELDIS JEROME B Executive VP of Research & Dev |
80,100 | $0 | 80,100 (Direct) |
View |
2022-04-05 Option Award |
2022-04-07 7:11 pm |
N/A 2032-04-04 |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
78,100 | $0 | 78,100 (Direct) |
View |
Ownership |
2022-04-07 7:10 pm |
N/A N/A |
NexImmune Inc. | NEXI | OELKE MATHIAS Chief Science Officer |
0 | $0 | 242,754 (Direct) |
View |
2021-12-21 Exercise |
2021-12-22 5:00 pm |
N/A N/A |
NexImmune Inc. | NEXI | Roemer Alan S. Director |
12,634 | $2.58 | 199,497 (Direct) |
View |
2021-12-21 Exercise |
2021-12-22 5:00 pm |
N/A N/A |
NexImmune Inc. | NEXI | Roemer Alan S. Director |
42,389 | $4.31 | 199,497 (Direct) |
View |
2021-12-21 Exercise |
2021-12-22 5:00 pm |
N/A N/A |
NexImmune Inc. | NEXI | Roemer Alan S. Director |
12,634 | $2.42 | 199,497 (Direct) |
View |
2021-12-21 Exercise |
2021-12-22 5:00 pm |
N/A 2027-03-02 |
NexImmune Inc. | NEXI | Roemer Alan S. Director |
67,657 | $0 | 199,497 (Direct) |
View |
2021-12-21 Exercise |
2021-12-22 08:00 am |
N/A N/A |
NexImmune Inc. | NEXI | BARER SOL J Director |
50,000 | $5.17 | 3,458,304 (Direct) |
View |
2021-12-21 Exercise |
2021-12-22 08:00 am |
2021-02-11 2030-03-04 |
NexImmune Inc. | NEXI | BARER SOL J Director |
50,000 | $0 | 3,458,304 (Direct) |
View |
2021-07-08 Exercise |
2021-07-09 4:19 pm |
N/A N/A |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
3,432 | $5.17 | 164,719 (Direct) |
View |
2021-07-08 Exercise |
2021-07-09 4:19 pm |
N/A 2030-03-04 |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
3,432 | $0 | 164,719 (Direct) |
View |
2021-06-08 Exercise |
2021-06-09 4:06 pm |
N/A N/A |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
3,432 | $5.17 | 164,719 (Direct) |
View |
2021-06-08 Exercise |
2021-06-09 4:06 pm |
N/A 2030-03-04 |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
3,432 | $0 | 164,719 (Direct) |
View |
2021-04-08 Exercise |
2021-05-19 4:16 pm |
N/A N/A |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
6,864 | $5.17 | 277,964 (Direct) |
View |
2021-04-08 Exercise |
2021-05-19 4:16 pm |
N/A 2030-03-04 |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
6,864 | $0 | 277,964 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 2:00 pm |
N/A N/A |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
3,432 | $5.17 | 193,706 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 2:00 pm |
N/A 2030-03-04 |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
3,432 | $0 | 193,706 (Direct) |
View |
2021-02-17 Conversion |
2021-02-19 4:30 pm |
N/A N/A |
NexImmune Inc. | NEXI | Jones Kristi Chief Operating Officer |
14,738 | $0 | 63,078 (Direct) |
View |
2021-02-17 Conversion |
2021-02-19 4:26 pm |
N/A N/A |
NexImmune Inc. | NEXI | Roemer Alan S. Director |
232,554 | $0 | 127,984 (Direct) |
View |
2021-02-17 Conversion |
2021-02-19 4:25 pm |
N/A N/A |
NexImmune Inc. | NEXI | Verstandig Grant Director |
5,141,566 | $0 | 714,895 (Direct) |
View |
2021-02-17 Conversion |
2021-02-19 4:23 pm |
N/A N/A |
NexImmune Inc. | NEXI | D'Angio Paul Director |
27,847 | $0 | 27,847 (Direct) |
View |
2021-02-17 Conversion |
2021-02-19 4:22 pm |
N/A N/A |
NexImmune Inc. | NEXI | Carmer Scott President and CEO |
7,058 | $0 | 7,058 (Direct) |
View |
2021-02-17 Conversion |
2021-02-19 4:22 pm |
N/A N/A |
NexImmune Inc. | NEXI | Bertram Timothy Director |
71,749 | $0 | 78,199 (Direct) |
View |
2021-02-17 Conversion |
2021-02-19 4:20 pm |
N/A N/A |
NexImmune Inc. | NEXI | BARER SOL J Director |
5,371,223 | $0 | 1,714,391 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:57 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | ZELDIS JEROME B Executive VP of Research & Dev |
351,016 | $0 | 351,016 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:56 pm |
N/A 2031-02-11 |
NexImmune Inc. | NEXI | Yao Zhengbin Director |
9,556 | $0 | 32,678 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:55 pm |
N/A 2031-02-11 |
NexImmune Inc. | NEXI | Verstandig Grant Director |
39,096 | $0 | 39,096 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:54 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
28,987 | $0 | 149,096 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:53 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | Roemer Alan S. Director |
9,556 | $0 | 104,191 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:51 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | Knight Robert Douglas Chief Medical Officer |
210,609 | $0 | 210,609 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:49 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | Jones Kristi Chief Operating Officer |
84,207 | $0 | 235,144 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:47 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | D'Angio Paul Director |
9,556 | $0 | 45,312 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:37 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | Carmer Scott President and CEO |
306,842 | $0 | 770,923 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:29 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | Bertram Timothy Director |
9,556 | $0 | 45,312 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 2:25 pm |
N/A 2025-02-11 |
NexImmune Inc. | NEXI | BARER SOL J Director |
19,113 | $0 | 225,013 (Direct) |
View |
Ownership |
2021-02-11 7:30 pm |
N/A N/A |
NexImmune Inc. | NEXI | Verstandig Grant Director |
0 | $0 | 538,771 (Direct) |
View |
Ownership |
2021-02-11 7:18 pm |
N/A N/A |
NexImmune Inc. | NEXI | Yao Zhengbin Director |
0 | $0 | 35,756 (Direct) |
View |
Ownership |
2021-02-11 7:08 pm |
N/A N/A |
NexImmune Inc. | NEXI | Trainer John Chief Financial Officer |
0 | $0 | 164,720 (Direct) |
View |
Ownership |
2021-02-11 7:04 pm |
N/A N/A |
NexImmune Inc. | NEXI | Roemer Alan S. Director |
0 | $0 | 222,594 (Direct) |
View |